JACC:T1DM患者CABG前血糖控制不佳会增加术后死亡或心血管事件的长期风险

2015-07-28 崔倩 译 MedSci原创

1型糖尿病患者(T1DM)有很高的心血管事件发生的风险。    这项研究的目的是探讨术前血红蛋白A1c(HbA1c)水平能否预测冠状动脉旁路移植术(CABG)后心血管或死亡事件。    这是一个全国性的,以人口为基础的观察性队列研究,这些患者是在瑞典1997年至2012年间所有的初次接受单独的非紧急CABG的T1DM患者,患者信息来自于瑞

1型糖尿病患者(T1DM)有很高的心血管事件发生的风险。
    
这项研究的目的是探讨术前血红蛋白A1c(HbA1c)水平能否预测冠状动脉旁路移植术(CABG)后心血管或死亡事件。
    
这是一个全国性的,以人口为基础的观察性队列研究,这些患者是在瑞典1997年至2012年间所有的初次接受单独的非紧急CABG的T1DM患者,患者信息来自于瑞典全国糖尿病登记和SWEDEHEART(根据推荐疗法对心脏病患者的循证治疗的增强和发展进行评估的瑞典网络系统)登记记录。我们计算了初发病率和95%可信区间(CIs),并使用Cox回归和多变量危险比(HRs)估计全因死亡率和主要心血管不良事件(MACE),主要是和HbA1c水平相关的心肌梗死,中风的风险,心脏衰竭,或重复血运重建事件。
    
共有764例T1DM患者被纳入研究中。在平均随访4.7年中,334(44%)例患者死亡或发生MACE事件(发生率:82例事件/ 1,000人-年)。多变量调整后,相对于参考类别,患者的HbA1c水平为7.1%至8.0%,8.1%至9.0%,9.1%至10.0%,和>10.0%时,死亡或MACE的HR(95%CI)分别为1.34(0.82至2.21),1.59(1.00至2.54),1.73(1.03至2.90),和2.25(1.29至3.94)。当HbA1c作为一个连续变量时,HbA1c水平增加1%时HR为1.18,95%Cl为1.06至1.32。
    
在T1DM患者中,CABG前血糖控制不佳增加了死亡或MACE的长期风险。

原始出处:

Thomas Nyström,Martin J. Holzmann, Björn Eliasson, Jeanette Kuhl,Ulrik Sartipy.Glycemic Control in Type 1 Diabetes and Long-Term Risk of Cardiovascular Events or Death After Coronary Artery Bypass Grafting,JACC,2015.7.28

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1643364, encodeId=bb171643364f1, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Feb 08 10:23:00 CST 2016, time=2016-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853377, encodeId=9f5e18533e75d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 24 20:23:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776745, encodeId=8ef11e76745e7, content=<a href='/topic/show?id=b4df89834a3' target=_blank style='color:#2F92EE;'>#血糖控制不佳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89834, encryptionId=b4df89834a3, topicName=血糖控制不佳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8438999619, createdName=wujh_7312832, createdTime=Tue Jul 12 12:23:00 CST 2016, time=2016-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272916, encodeId=eb5312e291670, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325068, encodeId=54481325068ae, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393669, encodeId=d7811393669d2, content=<a href='/topic/show?id=81721e04061' target=_blank style='color:#2F92EE;'>#T1DM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17040, encryptionId=81721e04061, topicName=T1DM)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401324, encodeId=9c04140132442, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519098, encodeId=74411519098c3, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1643364, encodeId=bb171643364f1, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Feb 08 10:23:00 CST 2016, time=2016-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853377, encodeId=9f5e18533e75d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 24 20:23:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776745, encodeId=8ef11e76745e7, content=<a href='/topic/show?id=b4df89834a3' target=_blank style='color:#2F92EE;'>#血糖控制不佳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89834, encryptionId=b4df89834a3, topicName=血糖控制不佳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8438999619, createdName=wujh_7312832, createdTime=Tue Jul 12 12:23:00 CST 2016, time=2016-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272916, encodeId=eb5312e291670, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325068, encodeId=54481325068ae, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393669, encodeId=d7811393669d2, content=<a href='/topic/show?id=81721e04061' target=_blank style='color:#2F92EE;'>#T1DM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17040, encryptionId=81721e04061, topicName=T1DM)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401324, encodeId=9c04140132442, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519098, encodeId=74411519098c3, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]
    2015-10-24 hbwxf
  3. [GetPortalCommentsPageByObjectIdResponse(id=1643364, encodeId=bb171643364f1, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Feb 08 10:23:00 CST 2016, time=2016-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853377, encodeId=9f5e18533e75d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 24 20:23:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776745, encodeId=8ef11e76745e7, content=<a href='/topic/show?id=b4df89834a3' target=_blank style='color:#2F92EE;'>#血糖控制不佳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89834, encryptionId=b4df89834a3, topicName=血糖控制不佳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8438999619, createdName=wujh_7312832, createdTime=Tue Jul 12 12:23:00 CST 2016, time=2016-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272916, encodeId=eb5312e291670, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325068, encodeId=54481325068ae, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393669, encodeId=d7811393669d2, content=<a href='/topic/show?id=81721e04061' target=_blank style='color:#2F92EE;'>#T1DM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17040, encryptionId=81721e04061, topicName=T1DM)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401324, encodeId=9c04140132442, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519098, encodeId=74411519098c3, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1643364, encodeId=bb171643364f1, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Feb 08 10:23:00 CST 2016, time=2016-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853377, encodeId=9f5e18533e75d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 24 20:23:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776745, encodeId=8ef11e76745e7, content=<a href='/topic/show?id=b4df89834a3' target=_blank style='color:#2F92EE;'>#血糖控制不佳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89834, encryptionId=b4df89834a3, topicName=血糖控制不佳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8438999619, createdName=wujh_7312832, createdTime=Tue Jul 12 12:23:00 CST 2016, time=2016-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272916, encodeId=eb5312e291670, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325068, encodeId=54481325068ae, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393669, encodeId=d7811393669d2, content=<a href='/topic/show?id=81721e04061' target=_blank style='color:#2F92EE;'>#T1DM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17040, encryptionId=81721e04061, topicName=T1DM)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401324, encodeId=9c04140132442, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519098, encodeId=74411519098c3, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1643364, encodeId=bb171643364f1, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Feb 08 10:23:00 CST 2016, time=2016-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853377, encodeId=9f5e18533e75d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 24 20:23:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776745, encodeId=8ef11e76745e7, content=<a href='/topic/show?id=b4df89834a3' target=_blank style='color:#2F92EE;'>#血糖控制不佳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89834, encryptionId=b4df89834a3, topicName=血糖控制不佳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8438999619, createdName=wujh_7312832, createdTime=Tue Jul 12 12:23:00 CST 2016, time=2016-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272916, encodeId=eb5312e291670, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325068, encodeId=54481325068ae, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393669, encodeId=d7811393669d2, content=<a href='/topic/show?id=81721e04061' target=_blank style='color:#2F92EE;'>#T1DM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17040, encryptionId=81721e04061, topicName=T1DM)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401324, encodeId=9c04140132442, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519098, encodeId=74411519098c3, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1643364, encodeId=bb171643364f1, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Feb 08 10:23:00 CST 2016, time=2016-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853377, encodeId=9f5e18533e75d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 24 20:23:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776745, encodeId=8ef11e76745e7, content=<a href='/topic/show?id=b4df89834a3' target=_blank style='color:#2F92EE;'>#血糖控制不佳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89834, encryptionId=b4df89834a3, topicName=血糖控制不佳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8438999619, createdName=wujh_7312832, createdTime=Tue Jul 12 12:23:00 CST 2016, time=2016-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272916, encodeId=eb5312e291670, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325068, encodeId=54481325068ae, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393669, encodeId=d7811393669d2, content=<a href='/topic/show?id=81721e04061' target=_blank style='color:#2F92EE;'>#T1DM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17040, encryptionId=81721e04061, topicName=T1DM)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401324, encodeId=9c04140132442, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519098, encodeId=74411519098c3, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1643364, encodeId=bb171643364f1, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Feb 08 10:23:00 CST 2016, time=2016-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853377, encodeId=9f5e18533e75d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 24 20:23:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776745, encodeId=8ef11e76745e7, content=<a href='/topic/show?id=b4df89834a3' target=_blank style='color:#2F92EE;'>#血糖控制不佳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89834, encryptionId=b4df89834a3, topicName=血糖控制不佳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8438999619, createdName=wujh_7312832, createdTime=Tue Jul 12 12:23:00 CST 2016, time=2016-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272916, encodeId=eb5312e291670, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325068, encodeId=54481325068ae, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393669, encodeId=d7811393669d2, content=<a href='/topic/show?id=81721e04061' target=_blank style='color:#2F92EE;'>#T1DM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17040, encryptionId=81721e04061, topicName=T1DM)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401324, encodeId=9c04140132442, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519098, encodeId=74411519098c3, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1643364, encodeId=bb171643364f1, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Mon Feb 08 10:23:00 CST 2016, time=2016-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853377, encodeId=9f5e18533e75d, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Oct 24 20:23:00 CST 2015, time=2015-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1776745, encodeId=8ef11e76745e7, content=<a href='/topic/show?id=b4df89834a3' target=_blank style='color:#2F92EE;'>#血糖控制不佳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89834, encryptionId=b4df89834a3, topicName=血糖控制不佳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d8438999619, createdName=wujh_7312832, createdTime=Tue Jul 12 12:23:00 CST 2016, time=2016-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1272916, encodeId=eb5312e291670, content=<a href='/topic/show?id=2f468983351' target=_blank style='color:#2F92EE;'>#血糖控制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89833, encryptionId=2f468983351, topicName=血糖控制)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef84111, createdName=whlxd, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325068, encodeId=54481325068ae, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1393669, encodeId=d7811393669d2, content=<a href='/topic/show?id=81721e04061' target=_blank style='color:#2F92EE;'>#T1DM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17040, encryptionId=81721e04061, topicName=T1DM)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401324, encodeId=9c04140132442, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519098, encodeId=74411519098c3, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Wed Jul 29 23:23:00 CST 2015, time=2015-07-29, status=1, ipAttribution=)]
    2015-07-29 huhuaidong391

相关资讯

JCEM:使用高葡萄糖钳夹和口服糖耐量试验对1型糖尿病患者的后代及兄弟姐妹中临床持续出现自身抗体阳性者进行3年的预测研究

研究背景: 在开展未来预防临床试验的过程中,我们旨在明确OGTT和高葡萄糖钳夹中的代谢指标能否作为预测因子预测1型糖尿病患者的后代及兄弟姐妹中胰岛自身抗体(autoAb+)持续阳性者中3年的糖尿病发病情况。 研究类型: 注册登记研究。 研究设计: 功能检测均在医院内完成。 受试者: 1型糖尿病患者一级亲属中持续出现autoAb+者(n=81,年龄在5-39

Diabetologia:循环sCD25浓度或可反映T1DM胰岛β细胞损伤

1型糖尿病患者循环sCD25浓度与C肽浓度的关系1型糖尿病是一种常见的自身免疫性疾病,有遗传和环境决定因素的。IL2和IL2RA(又名CD25)基因区内突变与1型糖尿病风险有关,这些蛋白表达或功能的变化有可能是病因。为了探讨1型糖尿病个体中,循环可溶性CD25浓度(sCD25,一种免疫激活和炎症的诊断指标)是否增加,并且研究循环sCD25浓度是否与C肽浓度(一种胰岛素分泌的

Diabetologia:白蛋白尿或可预测T1DM早期心功能异常

心力衰竭是1型糖尿病患者死亡的主要原因之一。因此,心力衰竭早期诊断对1型糖尿病至关重要。 为此,来自丹麦Steno糖尿病中心的Jensen教授及其团队进行了一项研究,试图确定在没有已知心脏病的1型糖尿病患者中,亚临床心脏收缩和舒张功能受损相关的患病率和临床特征。该研究结果发表在2014年04月的Diabetologia杂志上。 该研究是一项横断面调查,从Steno糖尿病中心随机选择了1093例

JCEM:1型糖尿病伴超重患者的肝脏脂肪含量及肝脏胰岛素敏感性研究

研究背景:1型糖尿病患者缺乏胰岛素在肝门静脉与外周之间的浓度梯度,这可能减弱胰岛素对肝脏脂质合成的刺激作用及对抗非酒精性脂肪性肝病(NAFLD)发展的保护作用。我们比较了1型糖尿病伴超重患者与非糖尿病患者的肝脏脂肪含量、肝糖合成及脂质分解的胰岛素敏感性。材料与方法:我们对年龄、BMI及性别匹配的32名超重1型糖尿病成人患者与32名非糖尿病患者进行比较。使用质子磁共振核磁波谱(1H-MRS)分析肝脏

Diabetes Care:睡眠或有助于T1DM患者血糖和血压控制

睡眠不足与胰岛素敏感性恶化有关。针对睡眠时间缩短对1型糖尿病患者产生影响的研究较少。睡眠缩减是否影响1型糖尿病患者的HbA1c水平仍是未知的。针对此问题,来自法国约瑟夫傅立叶大学国家卫生和医学研究学院(INSERM)缺氧病理生理学(HP2)实验室的Anne-Laure Borel博士等人进行了一项研究,研究发现,1型糖尿病患者睡眠时间缩短与高水平HbA1c以及非杓形高血压有关,并可能对微血管并发症

Diabetes Care:闭环胰岛素给药系统有益于预防T1DM患者夜间低血糖风险

1型糖尿病患者午后运动增加夜间低血糖(NH)风险。来自康涅狄格州耶鲁大学医学院儿科的Sherr博士等人进行了一项研究,研究假设:无论之前有或没有午后运动,在预防NH和维持夜间目标血糖范围内较高比例的血糖水平上,自动反馈控制的闭环(CL)胰岛素给药系统优于开环(OL)给药系统。研究发现,无论午后的活动水平如何,CL胰岛素给药系统是一种有效的降低NH风险的方法,同时增加血糖值在目标范围内的比例。研究结